Attached files

file filename
EX-31.1 - CERTIFICATION - LA JOLLA PHARMACEUTICAL COexhibit311.htm
EX-32.1 - CERTIFICATION - LA JOLLA PHARMACEUTICAL COexhibit321.htm
EX-31.2 - CERTIFICATION - LA JOLLA PHARMACEUTICAL COexhibit312.htm
EX-21.1 - SUBSIDIARIES OF LA JOLLA PHARMACEUTICAL COMPANY - LA JOLLA PHARMACEUTICAL COexhibit211.htm
EX-10.22 - EMPLOYMENT OFFER LETTER LAKHMIR CHAWLA - LA JOLLA PHARMACEUTICAL COexhibit1022.htm
10-K - 10-K - LA JOLLA PHARMACEUTICAL COljpc-20151231x10k.htm
EX-10.24 - UPDATED EMPLOYMENT OFFER LETTER JENNIFER ANNE CARVER - LA JOLLA PHARMACEUTICAL COexhibit1024.htm


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in Registration Statements (No. 333-206855) on Form S-3 and (No. 333-207212) on Form S-8 of La Jolla Pharmaceutical Company of our report dated February 25, 2016, relating to our audits of the consolidated financial statements and internal control over financial reporting, which appear in this Annual Report on
Form 10-K of La Jolla Pharmaceutical Company for the year ended December 31, 2015.



/s/ SQUAR MILNER LLP
(formerly Squar, Milner, Peterson, Miranda & Williamson, LLP)

San Diego California
February 25, 2016